4.12.2024 08:28:38 CET | Demant A/S |
Finanskalender
Selskabsmeddelelse nr. 2024-16 4. december 2024
Finanskalender for 2025
22. januar
Frist for indlevering af emner til dagsordenen for den ordinære generalforsamling*
15. januar til 4. februar
Stilleperiode forud for offentliggørelse af Årsrapport 2024
5. februar
Årsrapport 2024
6. marts
Ordinær generalforsamling
16. april til 6. maj
Stilleperiode forud for offentliggørelse af periodemeddelelse
6. maj
Periodemeddelelse for Q1 2025
23. juli til 12. august
Stilleperiode forud for offentliggørelse af Halvårsrapport 2025
12. august
Halvårsrapport 2025
15. oktober til 4. november
Stilleperiode forud for offentliggørelse af periodemeddelelse
4. november
Periodemeddelelse for Q3 2025
* Såfremt en aktionær ønsker et bestemt emne behandlet på den ordinære generalforsamling den 6. marts 2025, skal begæring herom indsendes skriftligt til bestyrelsen senest seks uger inden afholdelse af generalforsamlingen, således at begæringen er bestyrelsen i hænde senest den 22. januar 2025.
Yderligere information:
Peter Pudselykke, Head of Investor Relations
Telefon +45 2830 7638www.demant.com
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2024-16 Finanskalender 2025.pdf
4.12.2024 08:28:38 CET | Demant A/S |
Financial Calendar
Company announcement no 2024-16 4 December 2024
Financial calendar 2025
22 January
Deadline for submission of items for the agenda of the annual general meeting*
15 January to 4 February
Quiet period prior to publication of Annual Report 2024
5 February
Annual Report 2024
6 March
Annual general meeting
16 April to 6 May
Quiet period prior to publication of Interim Management Statement
6 May
Interim Management Statement for Q1 2025
23 July to 12 August
Quiet period prior to publication of Interim Report 2025
12 August
Interim Report 2025
15 October to 4 November
Quiet period prior to publication of Interim Management Statement
4 November
Interim Management Statement for Q3 2025
* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 6 March 2025, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2025.
Further information:
Peter Pudselykke, Head of Investor Relations
Phone +45 2830 7638www.demant.com
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2024-16 Financial calendar 2025.pdf
